These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1659 related items for PubMed ID: 18982862

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C, Onuma Y, Magro M, de Boer S, Battes L, van Domburg RT, Boersma E, Serruys PW, Interventional Cardiologists of the Thoraxcenter (2000-2005).
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):41-9. PubMed ID: 20310019
    [Abstract] [Full Text] [Related]

  • 23. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
    Daemen J, Tanimoto S, García-García HM, Kukreja N, van de Sande M, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW.
    Am J Cardiol; 2007 Apr 15; 99(8):1027-32. PubMed ID: 17437722
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions.
    Iakovou I, Ge L, Michev I, Sangiorgi GM, Montorfano M, Airoldi F, Chieffo A, Stankovic G, Vitrella G, Carlino M, Corvaja N, Briguori C, Colombo A.
    J Am Coll Cardiol; 2004 Sep 01; 44(5):967-71. PubMed ID: 15337205
    [Abstract] [Full Text] [Related]

  • 26. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
    Morice MC, Serruys PW, Barragan P, Bode C, Van Es GA, Stoll HP, Snead D, Mauri L, Cutlip DE, Sousa E.
    J Am Coll Cardiol; 2007 Oct 02; 50(14):1299-304. PubMed ID: 17903626
    [Abstract] [Full Text] [Related]

  • 27. Outcomes of overlapping bare-metal stents with sirolimus-eluting stents for long lesions in small coronary vessels.
    Kronsteiner E, Lee RW, Sweeney JP, Metallo JR, Stoehr JD, Fortuin FD.
    J Invasive Cardiol; 2010 Feb 02; 22(2):76-9. PubMed ID: 20124593
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
    Li JJ, Xu B, Yang YJ, Chen JL, Qiao SB, Ma WH, Qin XW, Yao M, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Gao RL.
    Chin Med J (Engl); 2007 Apr 05; 120(7):569-73. PubMed ID: 17442204
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Sirolimus-eluting stents for the treatment of bare-metal in-stent restenosis: long-term clinical follow up.
    Sheiban I, Chiribiri A, Beninati S, Moretti C, Omede P, Sciuto F, Marra WG, Biondi-Zoccai G, Bollati M, Gambino A, Trevi GP.
    J Invasive Cardiol; 2007 Apr 05; 19(4):174-80. PubMed ID: 17404403
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K.
    Coron Artery Dis; 2010 Jan 05; 21(1):46-56. PubMed ID: 19952925
    [Abstract] [Full Text] [Related]

  • 37. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.
    Han YL, Zhang J, Li Y, Wang SL, Jing QM, Yi XH, Ma YY, Luan B, Wang G, Wang B.
    Chin Med J (Engl); 2009 Mar 20; 122(6):643-7. PubMed ID: 19323927
    [Abstract] [Full Text] [Related]

  • 38. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
    Barlis P, Kaplan S, Dimopoulos K, Ferrante G, Di Mario C.
    Cardiology; 2008 Mar 20; 111(4):270-6. PubMed ID: 18451644
    [Abstract] [Full Text] [Related]

  • 39. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
    Simonton CA, Brodie B, Cheek B, Krainin F, Metzger C, Hermiller J, Juk S, Duffy P, Humphrey A, Nussbaum M, Laurent S, STENT Group.
    J Am Coll Cardiol; 2007 Sep 25; 50(13):1214-22. PubMed ID: 17888837
    [Abstract] [Full Text] [Related]

  • 40. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.
    Jeong YH, Hong MK, Lee CW, Park DW, Kim YH, Kim JJ, Park SW, Park SJ.
    Int J Cardiol; 2008 Mar 28; 125(1):36-40. PubMed ID: 17521753
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 83.